Chemaphor Inc. (TSX VENTURE:CFR), today announced that it has issued a total of
257,855 common shares in satisfaction of $24,496.99 in interest accrued to June
30, 2010 on convertible debentures issued by Chemaphor on April 30, 2009. 


Pursuant to the terms of the debentures, Chemaphor has the option to satisfy
interest payments by delivery of that number of common shares obtained by
dividing the interest payment by the market price of the common shares on the
TSX Venture Exchange at the time of settlement (determined in accordance with
TSX Venture Exchange rules). The applicable price per common share determined in
accordance with the terms of the debentures was $0.095, being the closing price
of the Chemaphor common shares on the TSX Venture Exchange on June 29, 2010.


About Chemaphor

Chemaphor, a wellness company, is committed to developing and delivering natural
health enhancer ("NHE") products to humans and animals to assist in optimizing
health and daily quality of life. Chemaphor is advancing NHE product candidates
for the food animal market, companion animal market and various, potential human
applications. More information can be found at www.chemaphor.com
Grafico Azioni Chemaphor Inc. (TSXV:CFR)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Chemaphor Inc.
Grafico Azioni Chemaphor Inc. (TSXV:CFR)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Chemaphor Inc.